About Bio INX
Bio INX is a company based in Ghent (Belgium) founded in 2022 by Agnes Dobos, Aysu Arslan, and Jasper Van Hoorick.. Bio INX has raised $500.63 thousand across 2 funding rounds. Bio INX offers products and services including Ready to use bio inks, Bio ink precursors, HYDROBIO INX U200, and DEGRAD INX U100. Bio INX operates in a competitive market with competitors including Nuclera Nucleics, CELLINK, OxSyBio, Collplant and Precise Bio, among others.
- Headquarter Ghent, Belgium
- Founders Agnes Dobos, Aysu Arslan, Jasper Van Hoorick
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bio Inx
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$500.63 K (USD)
in 2 rounds
-
Latest Funding Round
$500.63 K (USD), Seed
Sep 19, 2022
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bio INX
Bio INX offers a comprehensive portfolio of products and services, including Ready to use bio inks, Bio ink precursors, HYDROBIO INX U200, and DEGRAD INX U100. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Bioinks for 3D printing in tissue applications
Precursors for custom bioprinting solutions
Resin for advanced cancer research models
Biodegradable resin for high-resolution printing
Funding Insights of Bio INX
Bio INX has successfully raised a total of $500.63K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $500.63 thousand completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $500,625
-
First Round
First Round
(19 Sep 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Grant - Bio INX | Valuation |
investors |
|
| Sep, 2022 | Amount | Seed - Bio INX | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Bio INX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bio INX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bio Inx Comparisons
Competitors of Bio INX
Bio INX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, CELLINK, OxSyBio, Collplant and Precise Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Developer of integrated 3D printing and tissue-engineering platform
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bio Inx
Frequently Asked Questions about Bio INX
When was Bio INX founded?
Bio INX was founded in 2022.
Where is Bio INX located?
Bio INX is headquartered in Ghent, Belgium. It is registered at Ghent, East Flanders, Belgium.
Who is the current CEO of Bio INX?
Jasper Van Hoorick is the current CEO of Bio INX. They have also founded this company.
Is Bio INX a funded company?
Bio INX is a funded company, having raised a total of $500.63K across 2 funding rounds to date. The company's 1st funding round was a Grant of $200.25K, raised on Sep 19, 2022.
What does Bio INX do?
Bio INX was established in 2022 in Ghent, Belgium, within the advanced materials sector. A range of 3D printing inks is offered, encompassing multiphoton lithography formulations, deposition-based variants, and solutions for digital light processing and stereolithography. These inks are designed with shear-thinning properties to facilitate flow during application and maintain shape post-deposition. Operations focus on supporting precision manufacturing in biomedical and engineering applications.
Who are the top competitors of Bio INX?
Bio INX's top competitors include Nuclera Nucleics, Xlife sciences and Collplant.
What products or services does Bio INX offer?
Bio INX offers Ready to use bio inks, Bio ink precursors, HYDROBIO INX U200, and DEGRAD INX U100.